Latest News about NARI
Recent news which mentions NARI
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
January 12, 2025
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 07, 2025
From Benzinga
From Benzinga
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
January 07, 2025
From Benzinga
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
January 07, 2025
From Benzinga
Demystifying Inari Medical: Insights From 6 Analyst Reviews
December 17, 2024
Tickers
NARI
From Benzinga
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesday
October 29, 2024
From Benzinga
Breaking Down Inari Medical: 9 Analysts Share Their Views
October 09, 2024
Tickers
NARI
From Benzinga
Expert Outlook: Inari Medical Through The Eyes Of 9 Analysts
September 17, 2024
Tickers
NARI
From Benzinga
FDA Classifies Recall Of Inari Medical's Large Vessel Clot Removal Catheter Device As Most Serious
August 26, 2024
From Benzinga
Breaking Down Inari Medical: 7 Analysts Share Their Views
August 26, 2024
Tickers
NARI
From Benzinga
7 Leading MedTech Stocks for Next-Gen Health Solutions
July 31, 2024
From InvestorPlace
Tickers
NARI
From InvestorPlace
Why AMD Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 01, 2024
From Benzinga
From Benzinga
From Benzinga
Tickers
NARI
From InvestorPlace
Market Cap Game Show: Andy Cross vs. Bill Mann
March 30, 2024
From Motley Fool
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 29, 2024
From Benzinga
Shoals Technologies Posts Weak Q4 Results, Joins Butterfly Network, Schrödinger And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
February 29, 2024
From Benzinga
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
January 23, 2024
From Benzinga